Unknown

Dataset Information

0

Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial.

ABSTRACT:

SUBMITTER: Gallacher PJ 

PROVIDER: S-EPMC8185626 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial.

Gallacher Peter J PJ   Miller-Hodges Eve E   Shah Anoop S V ASV   Anand Atul A   Dhaun Neeraj N   Mills Nicholas L NL  

JAMA internal medicine 20210901 9

Similar Datasets

Unknown High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use.
| S-EPMC11581499 | biostudies-literature
Unknown TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial).
| S-EPMC6719714 | biostudies-literature
Unknown Acute Kidney Injury and High-Sensitivity Cardiac Troponin T Levels in the Emergency Department.
| S-EPMC11365000 | biostudies-literature
Unknown High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial.
| S-EPMC8177493 | biostudies-literature
Unknown Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay.
| S-EPMC7606506 | biostudies-literature
Unknown High-Sensitivity Cardiac Troponin T and Risk of Hypertension.
| S-EPMC4558242 | biostudies-literature
Unknown Coronary low-attenuation plaque and high-sensitivity cardiac troponin.
| S-EPMC10357930 | biostudies-literature
Unknown Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort.
| S-EPMC6398571 | biostudies-literature
Unknown Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.
| S-EPMC6384326 | biostudies-literature
Unknown Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.
| S-EPMC10655910 | biostudies-literature